Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development
News provided by
Share this article
Financialnewsmedia.com News Commentary
PALM BEACH, Fla., June 15, 2021 /PRNewswire/ The modern psychedelic renaissance has empirically proven that psychedelic drugs are going to revolutionize mental health treatment. Before these incredibly promising medicines can get to the people who need them the most, they must pass through the extensive drug development pipeline, where IP & Patents are crucial. It seems that a week doesn t go by without a psychedelic company saying it has filed for a new patent. An informative article on Microdose explains the reasons why psychedelic companies are pursuing these patents. First, the plants that the medicines are based on can t be patented. Products in nature belong to the public and thus can t be patented. Microdose wrote, One company cannot claim it as intellectual property to exclusively profit from it. How
Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Recently, the use of psychedelics is evolving for the treatment of a variety of mental illnesses, including anxiety, depression, post-traumatic.